Virtual Reality for Pain and Anxiety Relief During Peripheral Angioplasty
Launched by KASTAMONU UNIVERSITY · Jul 5, 2025
Trial Information
Current as of July 21, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring whether using virtual reality (VR) glasses can help reduce pain and anxiety during a common procedure called peripheral angioplasty, which is used to treat blocked arteries in the legs. Since this procedure is usually done with local anesthesia (numbing medicine) but no sedation, patients often feel uncomfortable and anxious. The study will compare patients who wear VR glasses during the procedure to those who don’t, to see if VR helps make the experience less painful and stressful.
People who are having a planned (not emergency) peripheral angioplasty and are able to wear VR glasses may be eligible to join. Participants will be randomly assigned to either use VR or not, and their pain and anxiety levels will be measured throughout the procedure. The study will also look at whether patients need extra medicine for pain or anxiety and how satisfied they feel overall. This trial is not yet recruiting, but it aims to find new ways to make the procedure easier and more comfortable for patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Undergoing elective peripheral angioplasty
- • Can cooperate and appropriate for wearing VR glasses
- Exclusion Criteria:
- • Undergoing emergency peripheral angioplasty
- • With neurological and psychiatric conditions that prevent reliable assessment of pain or anxiety scores
About Kastamonu University
Kastamonu University is a distinguished academic institution dedicated to advancing scientific research and innovation in health and medicine. With a strong emphasis on interdisciplinary collaboration, the university actively engages in clinical trials to explore new therapeutic approaches and improve patient outcomes. Leveraging its extensive network of researchers and healthcare professionals, Kastamonu University is committed to upholding the highest standards of ethical conduct and scientific rigor in its clinical research endeavors, ultimately contributing to the enhancement of public health and the development of evidence-based medical practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kastamonu, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported